510 related articles for article (PubMed ID: 34043628)
1. Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study.
Varma VR; Wang Y; An Y; Varma S; Bilgel M; Doshi J; Legido-Quigley C; Delgado JC; Oommen AM; Roberts JA; Wong DF; Davatzikos C; Resnick SM; Troncoso JC; Pletnikova O; O'Brien R; Hak E; Baak BN; Pfeiffer R; Baloni P; Mohmoudiandehkordi S; Nho K; Kaddurah-Daouk R; Bennett DA; Gadalla SM; Thambisetty M
PLoS Med; 2021 May; 18(5):e1003615. PubMed ID: 34043628
[TBL] [Abstract][Full Text] [Related]
2. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
3. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
Nho K; Kueider-Paisley A; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Jia W; Xie G; Ahmad S; Hankemeier T; van Duijn CM; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R;
Alzheimers Dement; 2019 Feb; 15(2):232-244. PubMed ID: 30337152
[TBL] [Abstract][Full Text] [Related]
4. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.
MahmoudianDehkordi S; Arnold M; Nho K; Ahmad S; Jia W; Xie G; Louie G; Kueider-Paisley A; Moseley MA; Thompson JW; St John Williams L; Tenenbaum JD; Blach C; Baillie R; Han X; Bhattacharyya S; Toledo JB; Schafferer S; Klein S; Koal T; Risacher SL; Kling MA; Motsinger-Reif A; Rotroff DM; Jack J; Hankemeier T; Bennett DA; De Jager PL; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn CM; Saykin AJ; Kastenmüller G; Kaddurah-Daouk R;
Alzheimers Dement; 2019 Jan; 15(1):76-92. PubMed ID: 30337151
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
[TBL] [Abstract][Full Text] [Related]
6. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
7. The value of surrogate markers to monitor cholesterol absorption, synthesis and bioconversion to bile acids under lipid lowering therapies.
Stellaard F; von Bergmann K; Sudhop T; Lütjohann D
J Steroid Biochem Mol Biol; 2017 May; 169():111-122. PubMed ID: 27060336
[TBL] [Abstract][Full Text] [Related]
8. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
[TBL] [Abstract][Full Text] [Related]
9. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
[TBL] [Abstract][Full Text] [Related]
10. Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.
Chuang YF; An Y; Bilgel M; Wong DF; Troncoso JC; O'Brien RJ; Breitner JC; Ferruci L; Resnick SM; Thambisetty M
Mol Psychiatry; 2016 Jul; 21(7):910-5. PubMed ID: 26324099
[TBL] [Abstract][Full Text] [Related]
11. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
Aliwa B; Horvath A; Traub J; Feldbacher N; Habisch H; Fauler G; Madl T; Stadlbauer V
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2676-2691. PubMed ID: 37767786
[TBL] [Abstract][Full Text] [Related]
12. Abnormal brain cholesterol homeostasis in Alzheimer's disease-a targeted metabolomic and transcriptomic study.
Varma VR; Büşra Lüleci H; Oommen AM; Varma S; Blackshear CT; Griswold ME; An Y; Roberts JA; O'Brien R; Pletnikova O; Troncoso JC; Bennett DA; Çakır T; Legido-Quigley C; Thambisetty M
NPJ Aging Mech Dis; 2021 Jun; 7(1):11. PubMed ID: 34075056
[TBL] [Abstract][Full Text] [Related]
13. Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.
Honda A; Miyazaki T; Iwamoto J; Hirayama T; Morishita Y; Monma T; Ueda H; Mizuno S; Sugiyama F; Takahashi S; Ikegami T
J Lipid Res; 2020 Jan; 61(1):54-69. PubMed ID: 31645370
[TBL] [Abstract][Full Text] [Related]
14. Impaired Bile Acid Synthesis in a Taurine-Deficient Cat Model.
Miyazaki T; Sasaki SI; Toyoda A; Shirai M; Ikegami T; Honda A
Adv Exp Med Biol; 2022; 1370():195-203. PubMed ID: 35882795
[TBL] [Abstract][Full Text] [Related]
15. Bile acid profile associated with CSF and PET biomarkers in Alzheimer's disease.
Nabizadeh F; Valizadeh P; Fallahi MS;
Aging Clin Exp Res; 2024 Mar; 36(1):62. PubMed ID: 38451317
[TBL] [Abstract][Full Text] [Related]
16. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
[TBL] [Abstract][Full Text] [Related]
17. Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice.
Song P; Zhang Y; Klaassen CD
Toxicol Sci; 2011 Oct; 123(2):359-67. PubMed ID: 21747115
[TBL] [Abstract][Full Text] [Related]
18. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.
Kakiyama G; Pandak WM; Gillevet PM; Hylemon PB; Heuman DM; Daita K; Takei H; Muto A; Nittono H; Ridlon JM; White MB; Noble NA; Monteith P; Fuchs M; Thacker LR; Sikaroodi M; Bajaj JS
J Hepatol; 2013 May; 58(5):949-55. PubMed ID: 23333527
[TBL] [Abstract][Full Text] [Related]
20. Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats.
Slopianka M; Herrmann A; Pavkovic M; Ellinger-Ziegelbauer H; Ernst R; Mally A; Keck M; Riefke B
Toxicology; 2017 Jul; 386():1-10. PubMed ID: 28529062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
